Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLL.L Regulatory News (CLL)

  • There is currently no data for CLL

Trading Statement

12 Jul 2007 07:00

Cello Group plc12 July 2007 12 July 2007 Cello Group plc Pre Close Trading Statement - six months to 30 June 2007 Cello Group plc ("Cello" AIM: CLL), the research and consulting group, todayprovides the following pre-close trading update for the six months to 30 June2007. Cello has continued to make good progress and the Board is confident about theGroup's outcome for the full year. The research and consulting business continues to perform well and on a fullyear basis is expected to deliver healthy growth. Our response business will bemore heavily second half weighted than in the past, but given good revenuevisibility which has strengthened since the AGM statement on 22 May, we areconfident about the full year outcome for this business. Our research and consulting business which now accounts for around 75% of theGroup on an operating profit basis has benefited from the investments made innew staff and product offering during the course of 2006 and the first half of2007. We have seen significant revenue growth from existing clients as well as anumber of large new client wins, particularly internationally. Internationalwork now accounts for 45% of the revenues of this division. The size ofcontracts we are pitching for and also winning has increased markedly, helpingdrive good like for like revenue growth. During the first six months of 2007, we further strengthened our healthcareresearch and consulting capability with the acquisition of The MSI Consultancyin March. In June, mruk research also joined the Group, strengthening ourresearch offer to the public sector. We have also made significant strides in building our online research business.In February we acquired a controlling interest in Digital People and Rosenblatt,and more recently we purchased a significant minority share in nqual, a dynamiconline qualitative research company. Our response business which comprises 25% of the Group continues to build astrong position in the sector, with healthy like for like revenue growth basedon good levels of revenue visibility. The seasonal split between the first andsecond half has continued to widen as the growth of the business has seen aparticular focus on clients with a seasonal spending pattern in both charitiesand financial services. This seasonality will affect like for like growth at aprofit level for the six months to 30 June but not on a full year basis where weare confident of good profit growth. We continue to increase the online component of our response offering, boththrough our separate branded offerings, Blonde and Oomph, as well as theincreasing component of our core offer that is now digital. On 6 July we announced the acquisition of cchm:ping, a specialist financialservices marketing agency and the establishment of a consulting offer in thissector vertical. In line with our prudent financing policy, Cello has maintained a strong balancesheet with low gearing. Cello expects to announce its interim results for the six months to 30 June 2007on Tuesday 11 September 2007. These results will be prepared under IFRS, and atransition statement will be issued prior to that date. Enquiries: Cello GroupKevin Steeds, Executive Chairman 020 7812 8460 College HillAdrian Duffield/Ben Way 020 7457 2020 Notes to Editors (www.cellogroup.co.uk) Cello is a market research and consulting group that listed on AIM in November2004. The Group's strategy is to create value for shareholders by building aportfolio of research and consulting businesses capable of advising blue chipclients globally. Cello has annualised turnover in excess of £100million, gross profits of over£50 million and employs approx 650 professional staff. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
17th Mar 20097:00 amRNSFinal Results
26th Feb 20098:00 amRNSNotice of Results
19th Jan 20097:00 amRNSYear end trading update
18th Dec 200812:38 pmRNSKevin Steeds
4th Dec 20087:00 amRNSDirector/PDMR Shareholding
30th Oct 20081:33 pmRNSChange of Adviser Name
16th Sep 20087:00 amRNSInterim Results
2nd Sep 20082:00 pmRNSInterim Board role change
18th Aug 20084:12 pmRNSNotice of Results
18th Aug 20081:13 pmRNSHolding(s) in Company
13th Aug 20082:16 pmRNSHolding(s) in Company
6th Aug 20082:56 pmRNSHolding(s) in Company
4th Jul 20087:00 amRNSHalf year trading update
24th Jun 200810:44 amRNSDirector/PDMR Shareholding
12th Jun 20081:22 pmRNSDirector/PDMR Shareholding
20th May 20081:25 pmRNSAGM Statement
23rd Apr 200812:59 pmRNSAnnual Report & AGM
17th Apr 20087:00 amRNSAdditional Listing / TVR
28th Mar 20086:11 pmRNSAdditional listing / TVR
25th Mar 20084:04 pmRNSDirector/PDMR Shareholding
19th Mar 20088:35 amRNSDirector/PDMR Shareholding
18th Mar 200810:40 amRNSPerformance Share Option Plan
18th Mar 20087:01 amRNSFinal Results
26th Feb 20087:01 amRNSTotal Voting Rights
13th Feb 200811:03 amRNSNotice of Results
17th Jan 200810:53 amRNSTransaction in Own Shares
16th Jan 20083:03 pmRNSDirector/PDMR Shareholding
16th Jan 20082:19 pmRNSTransaction in Own Shares
16th Jan 200810:54 amRNSTransaction in Own Shares
15th Jan 20087:00 amRNSTrading Statement
3rd Jan 20084:56 pmRNSNotification of Interests
21st Dec 20078:05 amRNSChange of Adviser
14th Dec 200711:10 amRNSDirector/PDMR Shareholding
30th Nov 20073:29 pmRNSTotal Voting Rights
24th Oct 20071:30 pmRNSDirector/PDMR Shareholding
24th Oct 20077:00 amRNSPerformance Share Option Plan
23rd Oct 20077:01 amRNSAcquisition
2nd Oct 20079:59 amRNSTransactions in own shares
26th Sep 200711:35 amRNSAdditional Listing
17th Sep 20077:01 amRNSAcquisition
11th Sep 20077:01 amRNSInterim Results
31st Aug 20075:08 pmRNSTVR Update
30th Aug 20079:15 amRNSAdoption of IFRS
20th Aug 20072:53 pmRNSNotice of Results
13th Aug 20074:40 pmRNSRule 26
30th Jul 20071:55 pmRNSAdditional Listing
20th Jul 200710:00 amRNSHolding(s) in Company
12th Jul 20077:00 amRNSTrading Statement
9th Jul 20072:06 pmRNSTotal Voting Rights
6th Jul 20077:01 amRNSAcquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.